New York, United States, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Neoantigens that arise from cancer-specific mutations are an additional class of antigens that are desirable for therapeutic cancer vaccines. Vaccination against tumour-specific neoantigens reduces the possibility of inducing central and peripheral tolerance, as well as the risk of autoimmunity.

纽约，美国，2023年10月26日（GLOBE NEWSWIRE）-由癌症特异性突变引起的新抗原是治疗性癌症疫苗所需的另一类抗原。针对肿瘤特异性新抗原的疫苗接种降低了诱导中枢和外周耐受的可能性，以及自身免疫的风险。

“Personalised medicines and Research and Development are driving the market,” states the Research Manager at Straits Research P. Ltd. Download Free Sample Report PDF @ https://straitsresearch.com/report/neoantigen-cancer-vaccine-market/request-sample KEY DRIVERS Nowadays, due to sedentary lifestyles, unhealthy diets, and at times even some sorts of addiction are catering to a rise in numbers of cancer cases.

“个性化药品和研发正在推动市场发展”，海峡研究有限公司研究经理说。下载免费样本报告PDF@https://straitsresearch.com/report/neoantigen-cancer-vaccine-market/request-sample当今的主要驱动因素，由于久坐不动的生活方式，不健康的饮食，有时甚至有某种成瘾正在吸引癌症病例的增加。

This drives the market for cancer treatment and the Neoantigen Cancer Vaccines. With new research and development, now it can be assured that Cancer can be prevented as well as cured. As each person’s health conditions are different, each body’s response to medicine is different. So, with the increasing awareness, the adoption of Personalized Medicine to Tailor Patient Treatment on an Individual Level has increased.

这推动了癌症治疗和新抗原癌症疫苗的市场。通过新的研究和开发，现在可以确保癌症可以预防和治愈。由于每个人的健康状况不同，每个人对药物的反应都不同。因此，随着意识的提高，个性化医疗在个人层面上量身定制患者治疗的采用也在增加。

This boosts the market for Neoantigen Cancer Vaccines. GROWTH OPPORTUNITIES The growth of the market for Neoantigen cancer vaccines is primarily attributable to rapid technological advancements and improvements in the healthcare industry's infrastructure. In addition to this, the increasing investments by governments and other healthcare providers are expected to create opportunities for the global neoantigen cancer vaccine market over the next few years.

这推动了新抗原癌症疫苗的市场。增长机会新抗原癌症疫苗市场的增长主要归功于技术的快速进步和医疗行业基础设施的改善。除此之外，政府和其他医疗保健提供者越来越多的投资预计将在未来几年为全球新抗原癌症疫苗市场创造机会。

The new research and development are creating a lot of things for the market like reducing treatment gaps, reducing turnaround time and cost etc. This.

新的研发正在为市场创造很多东西，如减少治疗差距，缩短周转时间和成本等。